title: Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor.
authors.affiliation: Zentrum Innere Medizin, Universitätskliniken, Göttingen.
authors.forename: J
authors.initials: J
authors.lastname: Thiery
authors.forename: V W
authors.initials: VW
authors.lastname: Armstrong
authors.forename: J
authors.initials: J
authors.lastname: Schleef
authors.forename: C
authors.initials: C
authors.lastname: Creutzfeldt
authors.forename: W
authors.initials: W
authors.lastname: Creutzfeldt
authors.forename: D
authors.initials: D
authors.lastname: Seidel
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood*; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019821:Simvastatin
chemical_list: D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017270:Lipoprotein(a); D008074:Lipoproteins; D008148:Lovastatin; D019821:Simvastatin